Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bright Minds Biosciences Inc. (TSE:DRUG)
:DRUG
Holding TSE:DRUG?
Track your performance easily
DRUG Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$1.29 - C$108.00
Previous CloseN/A
Volume70.00
Average Volume (3M)2.01K
Market Cap
C$378.17M
Enterprise ValueC$239.48K
Total Cash (Recent Filing)$799.93K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta26.01
Next Earnings
Mar 11, 2025EPS Estimate
-0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.69
Shares Outstanding6,988,989
10 Day Avg. Volume2,304
30 Day Avg. Volume2,013
Standard Deviation6.65
R-Squared0.00002
Alpha0.93
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap<0.01
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-0.11
Forecast
1Y Price Target
C$115.21Price Target Upside116.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Bright Minds Biosciences News
PremiumCompany Announcements
Bright Minds Biosciences to Present Novel Epilepsy Data
PremiumCompany Announcements
Bright Minds Biosciences Secures $35 Million InvestmentOptions Prices
Currently, No data available
---
Ownership Overview
28.44% Insiders
2.61% Other Institutional Investors
68.86% Public Companies and
Individual Investors
DRUG FAQ
What was Bright Minds Biosciences Inc.’s price range in the past 12 months?
Bright Minds Biosciences Inc. lowest stock price was C$1.29 and its highest was C$108.00 in the past 12 months.
What is Bright Minds Biosciences Inc.’s market cap?
Bright Minds Biosciences Inc.’s market cap is C$378.17M.
When is Bright Minds Biosciences Inc.’s upcoming earnings report date?
Bright Minds Biosciences Inc.’s upcoming earnings report date is Mar 11, 2025 which is in 52 days.
How were Bright Minds Biosciences Inc.’s earnings last quarter?
Bright Minds Biosciences Inc. released its earnings results on Aug 14, 2024. The company reported C$0.052 earnings per share for the quarter, beating the consensus estimate of N/A by C$0.052.
Is Bright Minds Biosciences Inc. overvalued?
According to Wall Street analysts Bright Minds Biosciences Inc.’s price is currently Undervalued.
Does Bright Minds Biosciences Inc. pay dividends?
Bright Minds Biosciences Inc. does not currently pay dividends.
What is Bright Minds Biosciences Inc.’s EPS estimate?
Bright Minds Biosciences Inc.’s EPS estimate is -0.5.
How many shares outstanding does Bright Minds Biosciences Inc. have?
Bright Minds Biosciences Inc. has 6,988,989 shares outstanding.
What happened to Bright Minds Biosciences Inc.’s price movement after its last earnings report?
Bright Minds Biosciences Inc. reported an EPS of C$0.052 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Bright Minds Biosciences Inc.?
Currently, no hedge funds are holding shares in TSE:DRUG
---
Bright Minds Biosciences Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
C$115.21 (116.03% Upside)
C$115.21 (116.03% Upside)
Blogger Sentiment
Bullish
TSE:DRUG Sentiment 70%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth C$117.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
1911.52%
12-Months-Change
Fundamentals
Return on Equity
-46.18%
Trailing 12-Months
Asset Growth
-11.26%
Trailing 12-Months
Company Description
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is a pre-clinical biosciences company. It is is focused on developing targeted therapies with the potential to improve the treatment of mental health and neurological disorders.
---
DRUG Stock 12 Month Forecast
Average Price Target
C$115.21
▲(116.03% Upside)
Technical Analysis
Best Analysts Covering DRUG
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+6.20%
initiated a buy rating 2 months ago
Copying Joel Beatty's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.20% per trade.
---